An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone who was using semaglutide (the drug in Ozempic/Wegovy) to lose weight wrote that they lost about 25 pounds in three months, then had a vacation with heavy drinking. After the trip their doctor ran blood tests and found unusually high liver enzyme levels, so the doctor stopped the medication to see if the liver numbers would improve. The person is asking whether anyone who switched from tirzepatide back to semaglutide had a similar experience. Semaglutide is a man-made version of a natural gut hormone that helps control appetite and blood sugar. In plain terms, it tells your brain you’re not as hungry and slows how quickly your stomach empties, so you feel fuller longer. It’s sold under brand names like Ozempic and Wegovy and is commonly used for weight loss and for treating type 2 diabetes. Tirzepatide is a newer drug that acts on two similar hormones instead of one, and it tends to produce bigger average weight loss in the trials, but both are taken by injection and can cause similar side effects. The snippet you shared is a single-person story — an anecdote. It’s not a study of many people, so it can’t prove cause and effect. Clinical trials and post-market reports show semaglutide can cause nausea, vomiting, and sometimes changes in liver tests, but serious liver injury is uncommon. Alcohol can also raise liver enzymes by itself, and combining heavy drinking with any medication could increase that risk. So in this case the high liver enzymes might be from the semaglutide, from heavy drinking, from their interaction, or from something else entirely; stopping the drug to see if the numbers fall is a standard cautious step doctors take. Why this matters is practical: people switching between GLP-1 drugs like semaglutide and newer combo drugs like tirzepatide want to know about safety and whether side effects will recur. If liver enzymes rose while on semaglutide, a doctor might avoid starting another similar drug right away or monitor blood tests more frequently. For someone who benefited from semaglutide’s weight loss, the question is whether trying tirzepatide or going back to semaglutide is worth the potential liver concern. This is especially relevant for people who drink heavily, have preexisting liver disease, or take other medications that affect the liver. Caveats: a single Reddit-style report doesn’t tell us much about risk rates or who is likely to have liver problems. Both semaglutide and tirzepatide are prescription medicines and should be managed by a clinician. Don’t assume causation from one case. If you have abnormal liver tests, your doctor may pause the drug, repeat labs, and consider alternatives. Heavy alcohol use, pregnancy, certain liver conditions, or interactions with other drugs are reasons to be extra cautious. Regulatory agencies currently approve these drugs for diabetes and some for weight management, but monitoring rules and guidance can vary. Bottom line: This is an individual report, not proof; if you or someone you know had liver issues on a GLP-1 drug, talk to your doctor before switching or restarting related medications, and expect closer liver monitoring.
Source: r/Semaglutide